Dashboard
Financial statements
DGX

Company financials

Quest Diagnostics

Health Care Health Care Services Secaucus, New Jersey Last filing Feb 26, 2026 · FY2025
Revenue FY2025
$11.0B
3y CAGR +3.7% P41
Net income FY2025
$992.0M
Net margin +9.0% P43
Total assets FY2025
$16.2B
ROA +6.1% P53
Operating cash flow FY2025
$1.9B
FCF margin +12.3% P37
20 yrs · FY2006–FY2025 9 filed · 0 derived · 0 blank

Each cell as a share of that year’s revenue.

Balance Sheet

Assets, liabilities, and equity

30 accounts · 10 years
Total assets $16.2B
Total liabilities $2.3B
Shareholders equity $7.2B
Account 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 Trend
Assets
Cash and Cash Equivalents 3.8% 5.6% 7.4% 3.2% 8.1% 12.3% 15.4% 1.8% 1.9% 5.0%
Accounts Receivable 12.8% 13.2% 13.1% 12.1% 13.3% 16.1% 13.8% 13.4% 12.5% 12.8%
Inventory 1.7% 1.9% 2.1% 1.9% 1.9% 2.4% 1.6% 1.3% 1.3% 1.1%
Prepaid Expenses 3.3% 3.6% 3.1% 2.0% 2.1% 1.7% 1.4% 1.9% 2.0% 2.1%
Total Current Assets 21.5% 24.2% 25.6% 19.2% 25.4% 32.4% 32.2% 18.5% 17.6% 21.2%
Property,Plant and Equipment 20.0% 21.4% 19.6% 17.9% 15.8% 17.2% 18.8% 17.1% 15.5% 14.3%
Operating Lease Assets 6.0% 6.6% 6.5% 5.9% 5.5% 6.4% 6.7%
Goodwill 81.1% 89.7% 83.6% 73.1% 65.8% 72.8% 85.7% 87.1% 85.6% 83.2%
Intangible Assets 14.8% 17.9% 12.6% 11.0% 10.8% 12.4% 14.5% 16.0% 15.1% 13.2%
Long Term Investments 1.2% 0.0% 0.0% 0.0% 0.0% 0.1% 0.2% 5.8% 6.2% 6.1%
Other Noncurrent Assets 2.4% 2.6% 2.1% 1.5% 1.5% 1.9% 2.1% 1.6% 1.8% 2.1%
Total Assets 147.0% 163.6% 151.6% 129.9% 126.2% 148.6% 166.2% 146.1% 141.9% 140.0%
Liabilities
Accounts Payable 14.5% 2.9% 4.1% 3.3% 3.3% 4.7% 3.4% 2.9% 3.0% 3.6%
Accrued Liabilities 0.0% 3.1% 3.1% 4.0% 4.3% 3.8% 2.9% 3.6% 3.3% 3.5%
Current Portion of Long Term Debt 4.6% 6.1% 3.3% 0.0% 0.0% 0.0% 10.4% 6.2% 0.5% 0.1%
Operating Lease Liabilities 1.6% 1.8% 1.7% 1.5% 1.4% 1.5% 1.9%
Other Current Liabilities 8.7% 9.5% 9.5% 8.2% 7.3% 9.0% 9.2% 9.9% 9.0% 9.1%
Total Current Liabilities 20.6% 22.0% 19.6% 15.7% 16.2% 18.8% 25.8% 19.7% 14.3% 13.6%
Long Term Debt 0.0% 56.9% 47.7% 40.3% 37.2% 42.5% 51.3% 45.5% 50.6% 51.7%
Operating Lease Liabilities Noncurrent 4.9% 5.4% 5.4% 4.9% 4.6% 5.3% 5.3%
Other Noncurrent Liabilities 8.7% 9.5% 9.5% 8.2% 7.3% 9.0% 9.2% 9.9% 9.0% 9.1%
Total Liabilities 20.6% 22.0% 19.6% 15.7% 16.2% 18.8% 25.8% 19.7% 14.3% 13.6%
Equity
Common Stock 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Additional Paid In Capital 21.6% 23.9% 25.1% 23.2% 20.9% 30.1% 35.2% 35.4% 35.3% 35.3%
Retained Earnings 90.6% 94.8% 95.4% 83.9% 70.9% 98.6% 105.8% 100.9% 96.4% 91.7%
Treasury Stock 46.9% 49.2% 52.2% 47.3% 32.0% 56.9% 67.5% 66.3% 64.6% 61.8%
Accumulated Other Comprehensive Income -0.2% -0.9% -0.2% -0.2% -0.1% -0.2% -0.5% -0.8% -0.6% -1.0%
Noncontrolling Interest 0.3% 0.4% 0.4% 0.4% 0.4% 0.5% 0.6% 0.7% 0.5% 0.4%
Total Stockholders Equity 65.0% 68.7% 68.2% 59.6% 59.7% 71.6% 73.0% 69.3% 66.5% 64.2%
Total Liabilitiesand Equity 147.0% 163.6% 151.6% 129.9% 126.2% 148.6% 166.2% 146.1% 141.9% 140.0%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 10 years
Ratio 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Profitability
Gross margin +33.2% +32.9% +33.0% +34.7% +39.0% +38.5% +34.8% +34.6% +36.2% +36.0%
Operating margin +14.1% +13.6% +13.6% +14.4% +22.1% +20.9% +15.9% +14.6% +15.7% +17.7%
Net margin +9.0% +8.8% +9.2% +9.6% +18.5% +15.2% +11.1% +9.8% +10.4% +8.9%
FCF margin +12.3% +9.2% +9.3% +13.3% +17.0% +16.8% +10.9% +10.8% +12.5% +11.4%
Growth
Revenue CAGR (3y) +3.7% -2.9% -0.7% +8.6% +12.7% +8.4% +2.3% +0.2% -0.1% +0.3%
Returns
ROE +13.8% +12.9% +13.5% +16.1% +31.0% +21.2% +15.2% +14.1% +15.7% +13.9%
ROA +6.1% +5.4% +6.1% +7.4% +14.7% +10.2% +6.7% +6.7% +7.4% +6.4%
ROIC +16.3% +8.3% +9.5% +11.7% +19.1% +15.5% +10.3% +9.9% +10.4% +9.7%
Liquidity
Current ratio 1.04x 1.10x 1.31x 1.22x 1.56x 1.72x 1.25x 0.94x 1.24x 1.56x
Quick ratio 0.80x 0.85x 1.04x 0.97x 1.32x 1.51x 1.13x 0.77x 1.00x 1.31x
Leverage
D/E 0.32x 0.32x 0.29x 0.26x 0.27x 0.26x 0.35x 0.28x 0.21x 0.21x
Interest coverage 778.00x 1346.00x 7.74x 9.65x 15.66x 11.87x 6.84x 6.51x 7.61x 8.87x
Efficiency
Asset turnover 0.68x 0.61x 0.66x 0.77x 0.79x 0.67x 0.60x 0.68x 0.70x 0.71x
Cash conversion cycle -23d +43d +37d +37d +40d +45d +40d +40d +36d +33d

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched
Saving notes adds DGX to your watchlist.